logo

For the Inventor, By the Inventor

Ami, Japan

Akira Ishibashi

This inventor holds 3 USPTO granted patents. Top assignees: Sagami Chemical Research Center, Mitsubishi Chemical Industries Limited, Mitsubishi Kasei Corporation. Active years: 1987-1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akira Ishibashi. Retrieved from https://idiyas.com/inventor/akira-ishibashi-7s6ptrq2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3

% Patents Active = 100.0

Average Co-Inventor Count = 6.9

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:

goldMedal2 out of 191 
 
Sagami Chemical Research Center
 patents
silverMedal1 out of 614 
 
Mitsubishi Chemical Industries Limited
 patents
bronzeMedal1 out of 499 
 
Mitsubishi Kasei Corporation
 patents
4. 1 out of 13 
 
Mitsubishi Yuka Pharmaceutical Co., Ltd.
 patents
where one patent can have more than one assignee

Years Active: 1987-1991

Loading Chart...
3 patents (USPTO):Explore Patents
1. 5053526 - Pharmaceuticals containing prostaglandin I.sub.2 (1991-10-01),
2. 4699921 - Pharmaceuticals containing prostaglandin I.sub.2 (1987-10-13),
3. 4668682 - 2-Phenylalkyl-3-aminoalkyl-4(3H)-quinazolinone compound (1987-05-26),

Title: Akira Ishibashi: Innovator in Pharmaceutical Chemistry

Introduction

Akira Ishibashi is a notable inventor based in Ami, Japan, recognized for his contributions to pharmaceutical chemistry. He holds a total of 3 patents that focus on innovative pharmaceutical compositions.

Latest Patents

His latest patents include formulations that contain prostaglandin I.sub.2 analogues, which are designed to have circulation ameliorating and antiulcer effects. These pharmaceuticals are characterized by their potent platelet aggregation inhibiting effect, blood pressure depressing effect, and vasodilative effect, while also being low in toxicity. The detailed chemical structures and configurations of these compounds highlight their complexity and potential therapeutic benefits.

Career Highlights

Throughout his career, Akira Ishibashi has worked with prominent companies such as Sagami Chemical Research Center and Mitsubishi Chemical Industries Limited. His work in these organizations has significantly contributed to advancements in pharmaceutical research and development.

Collaborations

Some of his notable coworkers include Daijiro Horii and Masakatsu Shibasaki, who have collaborated with him on various projects in the field of pharmaceutical innovations.

Conclusion

Akira Ishibashi's work in developing pharmaceutical compositions has made a significant impact in the field of medicine. His innovative approaches continue to influence the development of effective therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…